This course has expired. View available courses.
Men's Health
Testosterone Deficiency: Are You Ready for the Next Wave? – Mainpro+
This 1-hour eCME on the topic of testosterone deficiency syndrome (TDS) (also known as male hypogonadism, low testosterone, or “low T”) for the primary care audience will focus on improving counselling and adherence in the treatment of TDS. The majority of patients presenting to primary care for TDS symptoms have TDS as a result of […]
DURATION
1 hr
PROFESSION
Physician, Specialist
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2022-04-04
This 1-hour eCME on the topic of testosterone deficiency syndrome (TDS) (also known as male hypogonadism, low testosterone, or “low T”) for the primary care audience will focus on improving counselling and adherence in the treatment of TDS. The majority of patients presenting to primary care for TDS symptoms have TDS as a result of age-related physiological changes. Thus, as the population ages, the prevalence of TDS is expected to increase. Meanwhile, testosterone therapy preparations continue to evolve, and the Endocrine Society 2018 guideline update provides new recommendations for clinical management. This program supports primary care providers in keeping their knowledge of TDS up to date and working together with patients to understand the range of possible therapies and ensure optimal care.
Faculty
David Greenberg (BA, MD)
Francois Bénard (MD, FRCSC)
Frederic Crouzat (MD, CCFP)
Ted Jablonski (MD, CCFP, FCFP)
Learning objectives
Après avoir complété ce programme de formation, le participant devrait être mieux en mesure de :
- Décrire comment le profil glycémique ambulatoire (PGA) diffère des méthodes traditionnelles de rapports de glycémie;
- Distinguer entre les différents systèmes et dispositifs produisant des PGA qui sont disponibles pour surveiller la glycémie au Canada;
- Reconnaître la place nécessaire qu’occupe le PGA en tant que forme normalisée de présentation et d’interprétation des données de glycémie pour aider à la prise en charge du diabète en contexte de la pharmacie;
- Interpréter les résultats d’un PGA pour des patients souffrant de diabète de type 1 et de type 2;
- Identifier les principales variations apparaissant dans plusieurs PGA pour un même patient, et employer ces variations pour mettre en œuvre des ajustements thérapeutiques.